Danish stocks close in red after Easter holiday

The Danish C25 index closed down by 1.7% after the Easter holiday, primarily driven by a 7.4% drop in Novo Nordisk shares. As a significant component of the index due to its market value, Novo’s decline was influenced by favorable news for its American competitor Eli Lilly, which announced successful phase 3 study results for its weight-loss drug, orforglipron. Novo Nordisk’s weight-loss pill has not been approved. In the past year, Novo Nordisk’s stock has lost about 50% of its value. Additional declines included Zealand Pharma (-6.6%) and Ørsted (-4.8%). Market uncertainties increased following Donald Trump’s criticism of the US Fed Chair Jerome Powell, highlighting investors’ concerns about central bank independence. Overall, global markets have fluctuated with Trump’s recent trade policy announcements.